Patents & Intellectual Property
Patent portfolio, SIAE-registered software, licensing policy and links to WIPO/EPO registries.
Proprietary Patents
Portfolio of 5 proprietary patents in bioengineering and bioelectric technologies, verified and indexed on ORCID, and 3 software titles registered with the SIAE Special Public Register.
System and method for generating electrical energy exploiting the biochemical and physical properties of the human body
International patent covering an innovative system for the generation of electrical energy from the biochemical and physical properties of the human body, with applications in autonomous implantable medical devices.
System for the generation of bioelectricity
Italian patent for a system for the generation of bioelectricity, exploiting the biochemical and physical properties of the human body for powering implantable medical devices.
System for the generation of bioelectricity
Continuation of patent no. 102022000015195. Further development of the bioelectricity generation system, with improvements in endogenous bioelectric stimulation for medical devices.
Innovative system and method for tissue regeneration based on bioelectric principles
Italian patent for an innovative system and method for tissue regeneration, based on the application of bioelectric principles to stimulate the body's regenerative processes.
European extension of patented bioelectricity and medical device technologies
European-level extension of patented technologies relating to bioelectricity and medical devices, currently under examination at the European Patent Office (EPO).
Registered Software — SIAE Special Public Register
Computer programs deposited with the SIAE Special Public Register for Computer Programs, pursuant to Italian DPCM no. 244/94. Registration constitutes legal proof of authorship and certain date of the work.
SENTINEL-AI-INTELLIGENT-NETWORK
Multi-agent AI-powered Intrusion Detection System (IDS) for SME NIS2 compliance on ultra-low-resource edge devices. Operates on Raspberry Pi Zero 2 W hardware with 8 detection engines coordinated by 3 AI agents.
LIVEINK
Data mutability classification system (MC-TDC) and decoupled cache for AI inference optimisation. Integrates over 15 external data sources, Whisper AI transcription, multi-model fact-checking and embeddable JavaScript widget.
ATVAULT
Advanced secure digital asset management system integrating advanced cryptographic protocols and predictive artificial intelligence. Three-level security architecture: SENTINEL-AI (8 autonomous behavioural analysis agents), HashSigil (dual-chain certification BSC + Bitcoin/OpenTimestamps), end-to-end encrypted communication. Implements meta-transaction relay with native A&T token and on-chain digital inheritance protocol with time-based succession logic.
Legal notice — Registration with the SIAE Special Public Register under Italian DPCM no. 244/94 constitutes proof of prior art and authorship for copyright protection purposes (Italian Law 633/1941, Art. 2 no. 8). Published certificates are versions with personal data redacted under GDPR (EU Reg. 2016/679).
Licensing Policy
Technology Licences
IRST grants non-exclusive licences for its patented technologies (bioelectricity, energy harvesting, implantable medical devices) to industrial and academic partners, at market conditions compliant with EU Communication 2014/C 198/01. Available collaboration models include: technology licensing, joint development, component supply and proof-of-concept. For licensing enquiries: direzione@irst-institute.eu
Technology Transfer
IRST patented technologies are available for industrial integration in wearable, medical and IoT devices through the dedicated technology transfer platform. All licensing proceeds are fully reinvested in the Institute's primary research activities.
IP Protection Policy
IRST's intellectual property is protected in compliance with international patent law (PCT, EPO, UIBM), copyright law (Italian Law 633/1941 — SIAE registrations) and the eIDAS Regulation (EU 910/2014) for cryptographic certifications. Any reproduction, reverse engineering or unauthorised use will be prosecuted.